test

Mark Gottlieb

@Altium Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$339.708MTotal holdings77
Assets growth rate-99.86%Assets growth rate (2-Q avg)-51.42%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Altium Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 77 positions.

Assets under management

The assets under management (AUM) of Altium Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 339.708M in assets, with a quarterly growth rate of -99.86% and a 2-quarter average growth rate of -51.42%. The portfolio is managed by Mark Gottlieb, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
APREAprea Therapeutics Inc
Recent Activity
Exited
0%
$558.392M
137,197 shares@ $4070.01 avg price
SPRBSpruce Biosciences Inc
Recent Activity
Exited
0%
$419.941M
811,167 shares@ $517.7 avg price
EVOKEvoke Pharma Inc
Recent Activity
Exited
0%
$366.301M
692,440 shares@ $529.01 avg price
BOLDBoundless Bio Inc
Recent Activity
Exited
0%
$321.787M
83,149 shares@ $3870.01 avg price
LXRXLexicon Pharmaceuticals Inc
Recent Activity
Exited
0%
$204.936M
121,986 shares@ $1680.0 avg price
INBSIntelligent Bio Solutions In
Recent Activity
Exited
0%
$161.1M
83,906 shares@ $1920.01 avg price
PMNTPerfect Moment Ltd
Recent Activity
Exited
0%
$135.095M
62,835 shares@ $2150.0 avg price
CETXPCemtrex Inc
Recent Activity
Exited
0%
$74.791M
339,961 shares@ $220.0 avg price
QNRXQuoin Pharmaceuticals Ltd
Recent Activity
Exited
0%
$59.814M
103,127 shares@ $580.01 avg price
APDNApplied Dna Sciences Inc
Recent Activity
Exited
0%
$35.184M
86,152 shares@ $408.4 avg price